An experimental anti-obesity injection helped patients reach new levels of weight loss previously only achievable through bariatric surgery, according to new data from the pharmaceutical giant Eli Lilly. 

The new medication, retatrutide, appears to be the most powerful medication of its kind in a wave of injections and pills that have transformed obesity and diabetes management in recent years.